Published in Can J Physiol Pharmacol on January 01, 1971
In vitro effect of 6-hydroxydopamine on isolated rat atria. Br J Pharmacol (1972) 1.06
Role of the renal sympathetic nerves in the development and maintenance of hypertension in the spontaneously hypertensive rat. J Clin Invest (1980) 0.92
Regeneration of the noradrenergic innervation of the cardiovascular system of the chick following treatment with 6-hydroxydopamine. J Physiol (1974) 0.87
A physiological basis for subclassifying beta-adrenoceptors examined by chemical sympathectomy of guinea-pigs. J Physiol (1986) 0.86
The Galectin-1 level in serum as a novel marker for stress. Glycoconj J (2010) 0.85
Estrogen promotes sympathetic nerve regeneration in rat proximal urethra. Urology (2009) 0.85
Nonuniform cardiac denervation observed by 11C-meta-hydroxyephedrine PET in 6-OHDA-treated monkeys. PLoS One (2012) 0.85
Degeneration of sympathetic nerves in vitro and development of smooth muscle supersensitivity to noradrenaline. J Physiol (1972) 0.83
Blood pressure decrease in spontaneously hypertensive rats folowing renal denervation or dopamine β-hydroxylase inhibition with etamicastat. Hypertens Res (2015) 0.83
Neural control of the endocrine rat heart. Proc Natl Acad Sci U S A (1993) 0.78
Reversal of 6-hydroxydopamine-induced hypotension in the rat without activation of the renin-angiotensin system. J Physiol (1978) 0.77
The consequences of loss followed by recovery of noradrenergic nerve function on muscarinic receptors in the chick expansor secundariorum muscle. Br J Pharmacol (1987) 0.75
N-terminal proatrial natriuretic factor. An independent predictor of long-term prognosis after myocardial infarction. Circulation (1994) 2.05
Clinical and physiologic studies in pulmonary thromboembolism. Am J Cardiol (1967) 1.91
Treatment of microalbuminuria in hypertensive subjects with elevated cardiovascular risk: results of the IMPROVE trial. Kidney Int (2007) 1.67
Two-year time course and significance of neurohumoral activation in the Survival and Ventricular Enlargement (SAVE) Study. Eur Heart J (1998) 1.52
Overexpression of granulocyte-macrophage colony-stimulating factor induces pulmonary granulation tissue formation and fibrosis by induction of transforming growth factor-beta 1 and myofibroblast accumulation. Am J Pathol (1997) 1.50
Regulation of norepinephrine release from cardiac sympathetic fibers in the dog by presynaptic alpha- and beta-receptors. Circ Res (1977) 1.37
Circulating catecholamine levels in human and experimental hypertension. Circ Res (1976) 1.37
The nervous control of the circulation in the foetal and newly expanded lungs of the lamb. J Physiol (1965) 1.26
Prognostic value of neurohumoral activation in patients with an acute myocardial infarction: effect of captopril. J Am Coll Cardiol (1994) 1.24
Dysfunction of the beta- and alpha-adrenergic systems in a model of congestive heart failure. The pacing-overdrive dog. Circ Res (1991) 1.22
Influence of respiration on heart rate and blood pressure fluctuations. J Appl Physiol (1985) (1993) 1.19
Catecholamine metabolism in experimental hypertension in the rat. Circ Res (1967) 1.17
Transforming growth factor-beta gene transfer to the lung induces myofibroblast presence and pulmonary fibrosis. Curr Top Pathol (1999) 1.11
Correlation between the response of the heart to sympathetic stimulation and the release of endogenous catecholamines into the coronary sinus of the dog. Circ Res (1975) 1.09
Enhanced superoxide anion formation in vascular tissues from spontaneously hypertensive and desoxycorticosterone acetate-salt hypertensive rats. J Hypertens (2001) 1.05
Catecholamines in coronary sinus during exercise in man before and after training. J Appl Physiol Respir Environ Exerc Physiol (1977) 1.04
A reduction in the accumulation of H3-norepinephrine in experimental hypertension. Life Sci (1966) 1.03
Impaired basal sympathetic tone and alpha1-adrenergic responsiveness in association with the hypotensive effect of melatonin in spontaneously hypertensive rats. Am J Hypertens (1998) 0.97
Increased plasma catecholamine levels in patients with symptomatic mitral valve prolapse. Am J Med (1982) 0.96
Activation of neurohumoral systems in postinfarction left ventricular dysfunction. J Am Coll Cardiol (1993) 0.95
Inhibition by cyclic AMP of basal and induced inositol phosphate production in cultured aortic smooth muscle cells from Wistar-Kyoto and spontaneously hypertensive rats. J Hypertens (1996) 0.92
Plasma norepinephrine response to exercise before and after training in humans. J Appl Physiol Respir Environ Exerc Physiol (1981) 0.92
Cardiovascular effects of Buthus martensii (Karsch) scorpion venom. Toxicon (1994) 0.91
Abnormal storage of norepinephrine in experimental hypertension in the rat. Circ Res (1967) 0.91
Degeneration and regrowth of adrenergic nerve fibers in the rat peripheral tissues after 6-hydroxydopamine. Can J Physiol Pharmacol (1971) 0.90
Normal respiratory and circulatory values in the cat. J Appl Physiol (1965) 0.89
Oncostatin M, but not interleukin-6 or leukemia inhibitory factor, stimulates expression of alpha1-proteinase inhibitor in A549 human alveolar epithelial cells. J Interferon Cytokine Res (1997) 0.89
Human alveolar macrophages express elafin and secretory leukocyte protease inhibitor. Z Naturforsch C (2001) 0.89
Effects of Buthus martensii Karsch scorpion venom on the release of noradrenaline from in vitro and in vivo rat preparations. Can J Physiol Pharmacol (1994) 0.89
The clinical evaluation of hypertension. Can Fam Physician (1985) 0.89
Production of full-length human pre-elafin, an elastase specific inhibitor, from yeast requires the absence of a functional yapsin 1 (Yps1p) endoprotease. Protein Expr Purif (2000) 0.89
Localization of cardiac ectopic activity in man by a single moving dipole. Comparison of different computation techniques. J Electrocardiol (1985) 0.89
Effects of 6-hydroxydopamine on the canine sinus node. Circ Res (1971) 0.88
Changes in atrial rate during and following ventricular arrest from acetylcholine injections into the atrioventricular node artery of the dog. Can J Physiol Pharmacol (1967) 0.88
Plasma catecholamines in acute myocardial infarction. Am Heart J (1979) 0.88
Overexpression of Gi-proteins precedes the development of DOCA-salt-induced hypertension: relationship with adenylyl cyclase. Cardiovasc Res (1998) 0.88
Effects of chronic N-acetylcysteine treatment on the actions of peroxynitrite on aortic vascular reactivity in hypertensive rats. J Hypertens (2001) 0.86
The sympathetic system in hypertension. Clin Endocrinol Metab (1977) 0.85
The kinin B1 receptor antagonist SSR240612 reverses tactile and cold allodynia in an experimental rat model of insulin resistance. Br J Pharmacol (2007) 0.85
Abnormal regulation of cytosolic free calcium in vascular endothelial cells from spontaneously hypertensive rats. J Hypertens (1995) 0.85
Increased plasma catecholamines in patients with Friedreich's ataxia. Can J Neurol Sci (1982) 0.85
Effects of atenolol and hydrochlorothiazide on blood pressure and plasma catecholamines in essential hypertension. Hypertension (1983) 0.84
New body surface isopotential map evaluation method to detect minor potential losses in non-Q-wave myocardial infarction. Circulation (2000) 0.84
Increased apparent norepinephrine release rate in anesthetized DOCA-salt hypertensive rats. Clin Exp Hypertens A (1985) 0.84
Evidences supporting an increased sympathetic tone and reactivity in a subgroup of patients with essential hypertension. Clin Exp Hypertens (1980) 0.84
Sympathoadrenal mechanisms underlying cardiovascular responses to intrathecal substance P in conscious rats. J Cardiovasc Pharmacol (1990) 0.84
Protective effects of ceruloplasmin against electrolysis-induced oxygen free radicals in rat heart. Can J Physiol Pharmacol (1991) 0.83
Application of the single moving dipole inverse solution to the study of the Wolff-Parkinson-White syndrome in man. J Electrocardiol (1984) 0.83
The development of sympathetic innervation and the functional state of the cardiovascular system in newborn dogs. Can J Physiol Pharmacol (1975) 0.82
Alteration of prejunctional alpha 2-adrenergic autoinhibition in DOCA-salt hypertension. Am J Hypertens (1995) 0.82
Subcellular localization of monoamine oxidase in rat tissues. J Pharmacol Exp Ther (1969) 0.82
Muscarinic inhibition of endogenous myocardial catecholamine liberation in the dog. Can J Physiol Pharmacol (1978) 0.82
Neurohumoral and hemodynamic changes in congestive heart failure: lack of correlation and evidence of compensatory mechanisms. Am Heart J (1988) 0.81
Plasma norepinephrine, epinephrine, and dopamine beta-hydroxylase activity during exercise in man. Med Sci Sports Exerc (1985) 0.81
Echocardiographic assessment of left ventricular performance before and after marathon running. Am Heart J (1986) 0.81
Load elongation behavior of the canine anterior cruciate ligament. J Biomech Eng (1980) 0.81
Cardiovascular and sympathoadrenal responses to intrathecal injection of neuropeptide K in the conscious rat. Naunyn Schmiedebergs Arch Pharmacol (1993) 0.81
The intracortical distribution of norepinephrine, dopamine and serotonin in the cerebral cortex of the cat. Brain Res (1979) 0.80
Vasovagal syncope: management with atrioventricular sequential pacing and beta-blockade. Can J Cardiol (1990) 0.80
Norepinephrine-induced aortic hyperplasia and extracellular matrix deposition are endothelin-dependent. J Hypertens (2001) 0.80
QT interval prolongation and increased plasma catecholamine levels in patients with mitral valve prolapse. Am Heart J (1983) 0.80
Myocardial dysfunction and norepinephrine release in the isolated rat heart injured by electrolysis-induced oxygen free radicals. J Mol Cell Cardiol (1991) 0.80
Catecholamine release and ventricular arrhythmias during coronary occlusion and reperfusion in the dog. Can J Physiol Pharmacol (1985) 0.80
Effects of nicotine on heart rate studied by direct perfusion of sinus code. Am J Physiol (1967) 0.80
Representation of cardiac electrical activity by a moving dipole for normal and ectopic beats in the intact dog. Circ Res (1980) 0.80
A computer heart model incorporating anisotropic propagation. II. Simulations of conduction block. J Electrocardiol (1993) 0.79
Norepinephrine and dihydroxyphenylglycol effluxes from sympathetic nerve endings during hypoxia and reoxygenation in the isolated rat heart. Can J Physiol Pharmacol (1994) 0.79
Effects of renin-angiotensin blockade on sympathetic reactivity and beta-adrenergic pathway in the spontaneously hypertensive rat. Hypertension (1997) 0.79
Gender-related differences in advanced glycation endproducts, oxidative stress markers and nitric oxide synthases in rats. Kidney Int (2006) 0.79
DOCA-salt hypertensive rat hearts exhibit altered expression of G-proteins. Am J Hypertens (1993) 0.79
Narcolepsy and idiopthic hypersomnia: biogenic amines and related compounds in CSF. Neurology (1982) 0.79
Sodium and water excretion abnormalities in congestive heart failure. Determinant factors and clinical implications. Ann Intern Med (1986) 0.79
The behavior of atrio-ventricular nodal rhythm following direct perfusion of the sinus node. Can J Physiol Pharmacol (1966) 0.79
Selective perfusion of the AV node of the dog by cannulation of the posterior septal artery. Rev Can Biol (1965) 0.79
Altered cardiorespiratory transfer in hypertension. Hypertension (1994) 0.79
Sinus slowing produced by experimental ischemia of the sinus node in dogs. Am J Cardiol (1973) 0.79
The sympatho-adrenal tone and reactivity in human hypertension. Clin Exp Hypertens A (1989) 0.79
Altered calcium homeostasis in tail artery endothelial cells from spontaneously hypertensive rats. Am J Hypertens (1995) 0.79
Increased basal and reactive plasma norepinephrine and epinephrine levels in awake DOCA-salt hypertensive rats. J Auton Nerv Syst (1986) 0.79
Intradermal transgenic expression of granulocyte-macrophage colony-stimulating factor induces neutrophilia, epidermal hyperplasia, Langerhans' cell/macrophage accumulation, and dermal fibrosis. Lab Invest (1997) 0.79
Chronic hyperinsulinaemia and hypertension: the role of the sympathetic nervous system. J Hypertens (1995) 0.79
The nature of Wenckebach cycles. Can J Physiol Pharmacol (1969) 0.79
Enhanced sympathoadrenal reactivity to haemorrhagic stress in DOCA-salt hypertensive rats. J Hypertens (1989) 0.78
Chronic doxorubicin induced cardiomyopathy in rabbits: mechanical, intracellular action potential, and beta adrenergic characteristics of the failing myocardium. Cardiovasc Res (1990) 0.78
Local modulation of adrenal catecholamines release by beta-2 adrenoceptors in the anaesthetized dog. Naunyn Schmiedebergs Arch Pharmacol (1988) 0.78
Effect of antioxidant treatments on nitrate tolerance development in normotensive and hypertensive rats. J Hypertens (2000) 0.78
Role of the sinus node in the mechanism of cholinergic atrial fibrillation. Circ Res (1970) 0.78
Altered protein kinase C regulation of phosphoinositide-coupled receptors in deoxycorticosterone acetate-salt hypertensive rats. Hypertension (1994) 0.78
Alpha 2-adrenoceptor modulation of catecholamine and neuropeptide Y responses during haemorrhagic hypotension in anaesthetized dogs. J Auton Nerv Syst (1990) 0.78
Blood and plasma volume changes in dogs after sympathectomy with 6-hydroxydopamine. Can J Physiol Pharmacol (1977) 0.78
Transient involvement of endothelin in hypertrophic remodeling of small arteries. J Hypertens (2001) 0.78
Hyperresponsiveness of sympathoadrenal system in conscious DOCA-NaCl and SHR rats in response to acute hemorrhagic hypotension. Clin Invest Med (1992) 0.78
Alterations in circulating levels and cardiovascular tissue content of neuropeptide Y-like immunoreactivity during the development of deoxycorticosterone acetate-salt hypertension in the rat. J Hypertens (1992) 0.78
Reduction of tissue noradrenaline content in the isolated perfused rat heart during ischemia: importance of monoamine oxidation. Can J Physiol Pharmacol (1991) 0.78